Company research / VERA

Vera Therapeutics, Inc. (VERA)

Build a valuation ↗↓ Download CSV

CIK 0001831828

Key ratios (year ended 2025-12-31)

-49.6%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-09-04

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Operating Income	-$315.47M	-$167.17M	-$102.01M	-$90.90M	-$34.40M	-$52.24M	—
Net Income	-$299.62M	-$152.15M	-$95.99M	-$89.06M	-$32.61M	-$53.41M	—
EPS (Diluted)	$-4.66	$-2.75	$-2.25	$-3.35	$-2.43	—	—
Total Assets	$734.73M	$655.68M	$175.55M	$131.44M	$83.75M	$54.55M	—
Total Liabilities	$130.21M	$78.53M	$73.86M	$54.53M	$14.16M	$4.33M	—
Shareholders' Equity	$604.52M	$577.15M	$101.69M	$76.91M	$69.59M	-$89.35M	-$36.55M
Cash & Equivalents	$354.73M	$92.65M	$45.68M	$43.46M	$79.67M	$53.65M	—
Operating Cash Flow	-$241.10M	-$134.68M	-$92.18M	-$67.60M	-$23.71M	-$34.81M	—
Capital Expenditures	$630.0K	$972.0K	$63.0K	$62.0K	$0	$99.0K	—
Weighted Average Diluted Shares	64.23M	55.33M	42.71M	26.57M	13.44M	—	—
EPS (Basic)	$-4.66	$-2.75	$-2.25	$-3.35	$-2.43	—	—